Skip to main content
. 2016 Sep 28;6:32530. doi: 10.1038/srep32530

Table 3. Top-20 drug and disease associations in drug-disease module pair while Rank = 2.

Rank Drug name Disease name Score CTD mark
1 chlorpromazine Psychotic Disorders 5.36 T
2 chlorpromazine Schizophrenia 5.19 T
3 chlorpromazine Psychoses, Substance-Induced 5.19 M&T
4 perphenazine Schizophrenia 5.15 T
5 Thorazine Bipolar Disorder 5.07 M&T
6 thiothixene Psychotic Disorders 4.91 M&T
7 trifluoperazine Psychotic Disorders 4.72 T
8 trifluoperazine Psychoses, Substance-Induced 4.58 M
9 trifluoperazine Schizophrenia 4.57 T
10 thioridazine Psychoses, Substance-Induced 4.56 none
11 trifluoperazine Bipolar Disorder 4.54 T
12 fluphenazine Psychotic Disorders 4.42 T
13 fluphenazine Schizophrenia 4.24 T
14 fluphenazine Bipolar Disorder 4.16 T
15 fluphenazine Psychoses, Substance-Induced 4.10 M
16 thorazine Lewy Body Disease 4.07 inferred
17 perphenazine Bipolar Disorder 3.89 T
18 prochlorperazine Bipolar Disorder 3.81 none
19 perphenazine Psychotic Disorders 3.78 T
20 chlorpromazine Alcohol Withdrawal Delirium 3.68 none

CTD mark represents a drug-disease association is curated, inferred or not existed in CTD database. Curated associations include three types: marker/mechanism (CTD mark = “M”), therapeutic (CTD mark = “T”), marker/mechanism & therapeutic (CTD mark = “M&T”). If an association is inferred by CTD, CTD mark = “inferred”, and if it is not existed in CTD, CTD mark = “none”.